Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New policies for using anthelmintics in high risk groups.

Henrietta E Allen1, David W T Crompton, Nilanthi de Silva

  • 1Parasitic Diseases and Vector Control Unit, Dept of Communicable Diseases, Control, Prevention and Eradication, World Health Organization, 20 Avenue Appia, CH-1211 27 Geneva, Switzerland. allenh@who.int

Trends in Parasitology
|October 16, 2002
PubMed
Summary

This consultation addressed the safe use of praziquantel during pregnancy and lactation, and albendazole/mebendazole in young children. Key discussions focused on optimizing treatment strategies for parasitic infections in vulnerable populations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Residual Human Intestinal Nematode Infections Following Discontinuation of Mass Drug Administration in a Rural South Asian Setting: Implications for Deworming Surveillance.

Tropical medicine and infectious disease·2026
Same author

Post elimination of lymphatic filariasis: a situation analysis of brugian filariasis and vector potentialities within the filarial transmission belt in Sri Lanka.

Parasites & vectors·2026
Same author

mRNA vaccines encoding variant forms of Sm-TSP-2 confer protective immunity against Schistosoma mansoni.

NPJ vaccines·2025
Same author

Development of a Novel Compound Effective Against Juvenile, Adult, and Drug-Resistant <i>Schistosoma</i> Species.

Pharmaceutics·2025
Same author

mRNA vaccines encoding variant forms of Sm-TSP-2 confer protective immunity against Schistosoma mansoni.

Research square·2025
Same author

The Exodus and Its Toll: Sri Lanka's Economic Crisis and the Migration of Doctors.

The International journal of health planning and management·2025

Area of Science:

  • Public Health
  • Infectious Diseases
  • Pharmacology

Background:

  • Parasitic infections pose significant health risks globally.
  • Specific anthelmintic drug use in pregnant/lactating women and young children requires careful consideration.
  • Existing guidelines may not fully address safety and efficacy in these sensitive groups.

Purpose of the Study:

  • To discuss the appropriate use of praziquantel in pregnant and lactating women.
  • To review the safety and efficacy of albendazole and mebendazole in children under 24 months.
  • To provide recommendations for drug administration in vulnerable populations.

Main Methods:

  • An informal consultation was convened.
  • Expert opinions and available data were reviewed.

Related Experiment Videos

  • Discussions focused on drug safety, efficacy, and dosing.

    • Main Results:

    • The consultation highlighted the importance of risk-benefit assessments for drug use in pregnancy and lactation.
    • Data on albendazole and mebendazole use in young children were evaluated.
    • Consensus was sought on appropriate treatment protocols.

    Conclusions:

    • Safe and effective use of praziquantel, albendazole, and mebendazole is achievable with careful consideration.
    • Further research may be needed to fully elucidate safety profiles.
    • Recommendations were formulated to guide clinical practice.